This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.

To examine the comparative clinical and cost effectiveness of TomoTherapy, GammaKnife, and CyberKnife therapies for patients with cancer of the lung, central nervous system, or intra-abdomen.

Evidence is insufficient to reliably estimate the comparative clinical effectiveness (benefit and harm), cost effectiveness, and impact on quality of life of TomoTherapy, Gamma Knife surgery (GKS), or CyberKnife surgery (CKS). The specific patient caseloads and sites requiring radiosurgery or radiotherapy may be factors to consider before purchasing.

http://www.inahta.org/Publications/Briefs-Checklist-Impact/2009/4320/